BMI = body mass index; CVD = cardiovascular disease; DM = diabetes mellitus; HDL = high-density lipoprotein; IFN = interferon; NET = neuroendocrine tumor; SLE = systemic lupus erythematosus. The high ...

In this episode, Drs. Joseph Marine and Rajeev Pathak dive into the ARREST-AF trial and its implications for ablation outcomes in atrial fibrillation (AFib) patients. Listen as they explore the key ...

Days alive out of health care and hospitalization (DAoH), a novel measure of outcomes in children undergoing cardiovascular surgery, offers advantages over the traditional outcome measure of days ...

Among patients with takotsubo syndrome (TTS), beta-blocker therapy was associated with lower follow-up mortality but not lower TTS recurrence, according to a study published Feb. 5 in JACC: Heart ...

MedAxiom recently released the 2024 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which shows how APP leadership roles are beginning to guide new team-based care ...

Timing of surgical referral for pediatric atrioventricular septal defect (AVSD) is dependent on the subtype of AVSD with repair in infancy (3-6 months) for complete AVSD and repair during toddler ...

The ULTIMATE-DAPT (One-Month Ticagrelor Monotherapy After PCI in Acute Coronary Syndromes) trial data demonstrated that, in patients with acute coronary syndrome who underwent percutaneous coronary ...

ACC Chief Innovation Officer Ami B. Bhatt, MD, FACC, joined "The Digital Healthcare Experience" podcast for a discussion covering how artificial intelligence (AI) and clinicians can partner to enhance ...

In this episode of Conversations with Critical Care Cardiologists, we dive into the evolving landscape of education and training in Critical Care Cardiology (CCC). As this specialty rapidly advances, ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...

Secondary prevention medications for cardiovascular diseases (CVD) are underused globally and additional strategies to increase their use are needed to improve CVD management and reduce premature ...

Taylor receiving ACC's 2024 Pamela S. Douglas Award for Diversity and Inclusion at ACC.24 in Atlanta, GA. Herman A. Taylor's, MD, FACC, pioneering career in cardiovascular medicine has been ...